Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr;39(4):631-651.
doi: 10.1007/s11095-022-03232-y. Epub 2022 Mar 21.

Current and future strategies against cutaneous parasites

Affiliations
Review

Current and future strategies against cutaneous parasites

Ernest Man et al. Pharm Res. 2022 Apr.

Abstract

Cutaneous parasites are identified by their specific cutaneous symptoms which are elicited based on the parasite's interactions with the host. Standard anti-parasitic treatments primarily focus on the use of specific drugs to disrupt the regular function of the target parasite. In cases where secondary infections are induced by the parasite itself, antibiotics may also be used in tandem with the primary treatment to deal with the infection. Whilst drug-based treatments are highly effective, the development of resistance by bacteria and parasites, is increasingly prevalent in the modern day, thus requiring the development of non-drug based anti-parasitic strategies. Cutaneous parasites vary significantly in terms of the non-systemic methods that are required to deal with them. The main factors that need to be considered are the specifically elicited cutaneous symptoms and the relative cutaneous depth in which the parasites typically reside in. Due to the various differences in their migratory nature, certain cutaneous strategies are only viable for specific parasites, which then leads to the idea of developing an all-encompassing anti-parasitic strategy that works specifically against cutaneous parasites. The main benefit of this would be the overall time saved in regards to the period that is needed for accurate diagnosis of parasite, coupled with the prescription and application of the appropriate treatment based on the diagnosis. This review will assess the currently identified cutaneous parasites, detailing their life cycles which will allow for the identification of certain areas that could be exploited for the facilitation of cutaneous anti-parasitic treatment.

Keywords: anti-parasitic strategies; biomaterials; cutaneous; nanotechnology; parasites.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The life cycle of Leishmania.
Fig. 2
Fig. 2
The life cycle of the Ixodes tick.
Fig. 3
Fig. 3
The life cycle of myiasis larvae.
Fig. 4
Fig. 4
The life cycle of Pediculus humanus var. capitis.
Fig. 5
Fig. 5
The life cycle of Sarcoptes scabiei.
Fig. 6
Fig. 6
The life cycle of Tunga penetrans and Tunga trimamillata.
Fig. 7
Fig. 7
The life cycle of Gnathostoma nematodes.
Fig. 8
Fig. 8
The life cycle of Onchocerca volvulus.
Fig. 9
Fig. 9
The life cycle of strongyloidiasis parasites.

Similar articles

Cited by

References

    1. https://www.amboss.com/us/knowledge/Leishmaniasis. Accessed 01/02/22.
    1. Bravo F, Gontijo B. Gnathostomiasis: an emerging infectious disease relevant to all dermatologists. An Bras Dermatol. 2018;93(2):172–180. doi: 10.1590/abd1806-4841.20187498. - DOI - PMC - PubMed
    1. Herman JS, Chiodini PL. Gnathostomiasis, Another Emerging Imported Disease. Clin Microbiol Rev. 2009;22(3):484–492. doi: 10.1128/CMR.00003-09. - DOI - PMC - PubMed
    1. McGwire BS, Satoskar AR. Leishmaniasis: clinical syndromes and treatment. QJM. 2014;107(1):7–14. doi: 10.1093/qjmed/hct116. - DOI - PMC - PubMed
    1. Skar GL, Simonsen KA. Lyme Disease, StatPearls Publishing, Treasure Island, Florida, USA, 2022. - PubMed

LinkOut - more resources